Who are Lumoptik's investors?

Lumoptik's investors include Beresford Ventures.

How much funding has Lumoptik raised?

Lumoptik has disclosed $1M raised across 2 rounds.

Where is Lumoptik headquartered?

Lumoptik is headquartered in Washington Island, US.

Lumoptik

Washington Island, US · Delaware corporation · 1 known investors

Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.

Hardware Healthtech Medical Devices

Founders & leadership

Don VerleeMr. Verlee serves as Chief Scientific Officer of the issuer.

Frank LymanNamed on SEC filing

Thomas JanickiNamed on SEC filing

Andy AlexanderNamed on SEC filing

Board

Arthur JanickiMr. Janicki serves as a director of the issuer.

Jeff EnslinMr. Enslin serves as a director of the issuer.

Investors · 1

Beresford VenturesOrlando

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 2 rounds · 2019–2021

▶$900KraisedNov 2021 · 29 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Cole HatfieldExecutive Officer
Kurtz SanfordDirector
Frank LymanExecutive Officer, Director
Thomas JanickiDirector
Don VerleeExecutive Officer
Schumann RobertDirector
Brian KearnsDirector
Jeff EnslinDirector
Andy AlexanderExecutive Officer

Offering amount: $1.5M
Amount sold: $900K
Minimum investment: $10K
First sale: Mar 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100KraisedJun 2019 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Frank LymanExecutive Officer, Director
Thomas JanickiDirector
Jeff EnslinDirector
Andy AlexanderExecutive Officer
Arthur JanickiDirector
Don VerleeExecutive Officer

Offering amount: $1.5M
Amount sold: $100K
Minimum investment: $25K
Sales commissions: $105K
Placement agents: Cova Capital Partners
First sale: May 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Lumoptik - TCA Venture Grouptcaventuregroup.com · Dec 2022

Frequently asked questions

What does Lumoptik do?: Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.
Who are Lumoptik's investors?: Lumoptik's investors include Beresford Ventures.
How much funding has Lumoptik raised?: Lumoptik has disclosed $1M raised across 2 rounds.
Where is Lumoptik headquartered?: Lumoptik is headquartered in Washington Island, US.